Aehr Test's stock surged 8.33% during intraday trading on Tuesday, staging a dramatic reversal after earlier declines in the session.

The recovery was driven by oversold conditions following consecutive sharp declines from the stock's 52-week high, combined with buying interest at depressed levels. The company's previously secured $41 million AI chip testing order provided fundamental support for the stock's rebound.

The broader semiconductor equipment sector also contributed to the positive momentum, with industry peers showing gains during the same trading session, creating a favorable environment for Aehr Test's recovery.